We are live on ! Find out more
MOBXW icon

Mobix Labs Warrants

15 hedge funds and large institutions have $147K invested in Mobix Labs Warrants in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

15.68% more ownership

Funds ownership: 0%15.68% (+16%)

7% more funds holding

Funds holding: 1415 (+1)

8% less capital invested

Capital invested by funds: $159K → $147K (-$12.1K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
3
Closed
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
-$1K

MOBXW Hedge Fund Activity: Q2 2025 in Review

15 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Mobix Labs Warrants (MOBXW) for Q2 2025, worth a combined $147K — down 7.6% from $159K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MOBXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $9. The largest seller was Wolverine Asset Management, cutting an estimated $4.36K.

  • 15 institutional investors held Mobix Labs Warrants (MOBXW) as of Q2 2025, up from 14 in Q1 2025.
  • Funds reported $147K of Mobix Labs Warrants stock for Q2 2025, down 7.6% quarter-over-quarter.
  • 1 fund opened new Mobix Labs Warrants positions in Q2 2025 and 0 closed out, a net change of +1 holder.
  • The largest Mobix Labs Warrants buyer in Q2 2025 was Toronto Dominion Bank, an estimated $9 added.
  • The largest Mobix Labs Warrants seller in Q2 2025 was Wolverine Asset Management, an estimated $4.36K sold.

Based on aggregated 13F filings for Q2 2025.